<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0">
<channel>
<title>Chinese Journal of Magnetic Resonance Imaging RSS feed</title>
<link>http://med-sci.cn/cgzcx/en/contents_list.asp?issue=202608</link>
<language>zh-cn</language>
<copyright>An RSS feed for Chinese Journal of Magnetic Resonance Imaging</copyright>
<item>
<title><![CDATA[Topological characteristics of cerebral blood flow networks based on regional CBF morphological similarity in patent foramen ovale and their associations with cognitive function]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.002</link>
<description><![CDATA[<b>Objective</b>To construct a cerebral blood flow (CBF) functional network based on arterial spin labeling (ASL) and to investigate alterations in network topological properties in patients with patent foramen ovale (PFO) and their associations with cognitive function. <b>Materials and Methods</b>A total of 52 patients with PFO and 48 age- and sex-matched healthy controls were prospectively enrolled. CBF was quantified using ASL. The cerebral cortex was parcellated into 200 regions of interest according to the Schaefer atlas. The probability distribution of CBF in each region was estimated using kernel density estimation, and Jensen-Shannon divergence (JSD) was applied to quantify distributional similarity and construct the CBF functional network. Global and nodal topological properties, including global efficiency, clustering coefficient, degree centrality, and nodal efficiency, were calculated. Between-group differences were assessed using independent-samples <i>t</i>-tests. Partial correlation analyses controlling for age, sex, and years of education were further performed to investigate the relationships between abnormal network topological properties and cognitive function. Specifically, we examined correlations with Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) scores, as well as with PFO anatomical parameters and right-to-left shunt (RLS) grades. <b>Results</b>(1) Global properties: Compared with healthy controls, patients with PFO showed a statistically significant difference in global efficiency at the uncorrected level (<i>P</i> &lt; 0.05), but the difference was not statistically significant after Bonferroni correction. (2) Nodal properties: Compared with the HC group, patients with PFO exhibited significant nodal topological alterations across multiple functional networks. In the default mode network (DMN), the degree centrality (Dc) and nodal efficiency (Ne) of the left precuneus were significantly decreased, while the Ne and nodal local efficiency (NLe) of the left dorsal prefrontal cortex were reduced. The left posterior cingulate cortex showed decreased Dc and Ne, with increased nodal clustering coefficient (NCp) and NLe. In the right posterior cingulate cortex, betweenness centrality (Bc), Dc, and Ne were decreased, while nodal shortest path length (NLp) was increased. In the fronto-parietal control network (FPN), the right dorsolateral prefrontal cortex showed decreased Bc, Dc, and Ne, whereas NCp and NLe were increased. In the somatomotor network (SMN), the left somatomotor area showed increased Bc, Dc, and Ne, along with decreased NLp. The right somatomotor area demonstrated increased Bc, Dc, and Ne, whereas the right secondary somatosensory cortex showed decreased Bc, Dc, and Ne. In the ventral attention network (VAN), the right inferior parietal lobule exhibited decreased Ne, accompanied by increased NLe and NLp (FDR corrected <i>P </i>&lt; 0.05). (3) Correlation analysis: In the right posterior cingulate cortex, Bc and Dc were positively correlated with MoCA scores, while Ne and Dc were positively correlated with MMSE scores. In the left precuneus, Ne was positively correlated with MoCA scores. In the left posterior cingulate cortex, Dc, NCp, and NLe were positively correlated with MoCA scores, while Ne, Dc, NCp, and NLe were positively correlated with MMSE scores (FDR corrected <i>P</i> &lt; 0.05). <b>Conclusions</b>Patients with PFO exhibit significant topological reorganization at the nodal level of the CBF network, primarily involving key functional networks such as the default mode network, fronto-parietal control network, and somatomotor network, and these alterations are correlated with cognitive scores. These findings may reveal potential neural mechanisms underlying PFO-related cognitive changes, provide preliminary insights into the relationship between nodal-level network topological changes and cognitive function, and offer an additional neuroimaging perspective for the assessment of cognitive function in patients with PFO. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Study on effective connectivity characteristics of brain in youth with subthreshold depression based on rs-fMRI and spectral dynamic causal modeling]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.003</link>
<description><![CDATA[<b>Objective</b>To investigate the characteristics of effective connectivity in youth with subthreshold depression (SD) and reveal its early neuropathological mechanism based on resting-state functional magnetic resonance imaging (rs-fMRI) and spectral dynamic causal modeling (spDCM). <b>Materials and Methods</b>Fifty-two participants with SD (SD group) and 51 healthy controls (HC group) aged 15-24 years were enrolled. After preprocessing all rs-fMRI data, we selected the left dorsolateral prefrontal cortex (lDLPFC), right dorsolateral prefrontal cortex (rDLPFC), medial prefrontal cortex (mPFC), and posterior cingulate cortex (PCC) as regions of interest. Effective connectivity (EC) differences were analyzed using spDCM and parametric empirical Bayes (PEB). Correlation analyses were performed between interregional effective connectivity values and clinical scale scores in the SD group. <b>Results</b>In both groups, bilateral DLPFC exerted inhibitory connectivity toward mPFC and PCC (EC range: -0.435 to -0.200, <i>Pp </i>&gt; 0.95). The mPFC exhibited excitatory connectivity to rDLPFC (EC = 0.075, <i>Pp </i>&gt; 0.95), and bidirectional excitatory connectivity was observed between lDLPFC and rDLPFC (EC range: 0.206 to 0.256, <i>Pp </i>&gt; 0.95). Compared with the HC group, the SD group exhibited decreased inhibitory effective connectivity from rDLPFC to mPFC (EC = 0.118, <i>Pp </i>&gt; 0.95). No significant correlations were observed between interregional connectivity strengths in the SD group and scores of the 24-item Hamilton Depression Rating Scale (HAMD-24) as well as the Self-Rating Depression Scale (SDS) (<i>r</i> range: -0.215 to 0.254, all <i>P</i> &gt; 0.05). <b>Conclusions</b>Youth with SD exhibit reduced inhibitory effective connectivity from rDLPFC to mPFC, suggesting that reduced inhibitory control of mPFC by rDLPFC is a concomitant neuroimaging feature of early SD, which can be used as an imaging reference to reflect brain functional alterations in SD. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Resting-state fMRI on the functional connectivity regulation of the default mode network in chronic subjective tinnitus patients using Zhu<sup><sup>,</sup></sup>s scalp acupuncture]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.004</link>
<description><![CDATA[<b>Objective</b>To explore the regulatory effect of Zhu<sup><sup>,</sup></sup>s scalp acupuncture on the functional connectivity of the default mode network (DMN) in patients with chronic subjective tinnitus (CST) based on resting-state functional magnetic resonance imaging (rs-fMRI) technology, clarify its associated brain functional network changes and verify the clinical efficacy. <b>Materials and Methods</b>A total of 85 CST patients meeting the inclusion criteria from March 2025 to October 2025 were selected and randomly divided into an experimental group (Zhu<sup><sup>,</sup></sup>s scalp acupuncture treatment, 43 cases) and a control group (oral administration of Ginkgo Biloba tablets and mecobalamin, 42 cases) using a random number table method. Additionally, 30 healthy volunteers were included as a healthy control group, which underwent only a single baseline rs-fMRI scan. Patients in both treatment groups received intervention for (60 ± 2) days and underwent rs-fMRI scans before and after treatment. Simultaneously, the Tinnitus Handicap Inventory (THI), Hamilton Anxiety and Depression Scale (HADS), Pittsburgh Sleep Quality Index (PSQI), and Visual Analogue Scale (VAS) were assessed. Sliding window analysis, hidden Markov models, and graph theory analysis were employed to extract functional connectivity parameters of core DMN nodes [posterior cingulate cortex (PCC), medial prefrontal cortex (mPFC), angular gyrus (ANG), etc.) and graph theory metrics (global efficiency, local efficiency, clustering coefficient). Dynamic changes in DMN functional connectivity before and after treatment were compared between the two groups, and the correlation between imaging indicators and clinical scale scores was analyzed. <b>Results</b>Before treatment, the functional connectivity strengths between PCC and ANG, as well as between mPFC and PCC in the DMN of patients in both groups were higher than those of healthy people (<i>t </i>= 5.342, <i>P </i>&lt; 0.001; <i>t </i>= 6.115, <i>P </i>&lt; 0.001), and were positively correlated with THI scores (<i>r </i>= 0.583, 0.612, <i>P </i>&lt; 0.01). After treatment, the functional connectivity strengths of PCC-right ANG and mPFC-PCC in the experimental group were lower than those before treatment (<i>t </i>= 8.756, <i>P </i>&lt; 0.001; <i>t </i>= 9.234, <i>P </i>&lt; 0.001), and the global efficiency, local efficiency and clustering coefficient of DMN were improved (<i>t </i>= 7.562, 7.236, 6.982, <i>P </i>&lt; 0.001); the improvement amplitude of the above imaging indicators in the experimental group was better than that in the control group (<i>t </i>= 3.878, 3.652, 3.423, <i>P </i>&lt; 0.05). In terms of clinical efficacy, the total effective rate of the experimental group (86.05%) was significantly higher than that of the control group (64.29%) (<i>χ</i><sup>2</sup> = 6.327, <i>P </i>= 0.012). Correlation analysis showed that the change in PCC-right ANG functional connectivity strength was positively correlated with the change in THI score (<i>r </i>= 0.623, <i>P </i>&lt; 0.001). <b>Conclusions</b>Zhu<sup><sup>,</sup></sup>s scalp acupuncture can improve clinical symptoms by down-regulating the abnormally enhanced functional connectivity in the DMN of CST patients and optimizing the network topological properties. Its mechanism may be related to regulating DMN functional connectivity and network topological properties, which provides imaging evidence for the precise treatment of CST. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Evaluation of white matter microstructural impairment in temporal lobe epilepsy using peak width of skeletonized mean diffusivity]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.005</link>
<description><![CDATA[<b>Objective</b>To explore the clinical value of the peak width of skeletonized mean diffusivity (PSMD) parameter in reflecting white matter damage and disease severity in patients with temporal lobe epilepsy (TLE). <b>Materials and Methods</b>A total of 32 patients with temporal lobe epilepsy with hippocampal sclerosis (TLE-HS), 31 patients with nonlesional temporal lobe epilepsy (TLE-NL), and 40 healthy controls (HC) were included. Diffusion tensor imaging (DTI) data of the brain were collected to calculate whole-brain white matter PSMD values. Differences among the three groups were compared, and the correlations between PSMD and disease duration, the National Hospital Seizure Severity Scale (NHS<sub>3</sub>), as well as the Montreal Cognitive Assessment (MoCA) were analyzed. <b>Results</b>The overall distribution of PSMD values differed significantly among the three groups (<i>H </i>= 17.950, <i>P</i> &lt; 0.001). Post-hoc pairwise comparisons showed that the overall PSMD level in the TLE-HS group was higher than that in the HC group (<i>P</i> &lt; 0.001). No statistically significant differences were observed between the TLE-NL group and the HC group, or between the TLE-HS group and the TLE-NL group. In the TLE-HS group, PSMD values were positively correlated with disease duration (<i>r </i>= 0.416, <i>P </i>= 0.018) and NHS<sub>3</sub> scores (<i>r </i>= 0.542, <i>P </i>= 0.001), and negatively correlated with MoCA scores (<i>r </i>= -0.428, <i>P </i>= 0.015). In the TLE-NL group, PSMD values were positively correlated with disease duration (<i>r </i>= 0.423, <i>P </i>= 0.018) and NHS<sub>3</sub> scores (<i>r </i>= 0.328, <i>P </i>= 0.072), but the latter correlation did not reach statistical significance. PSMD values in the TLE-NL group were negatively correlated with MoCA scores (<i>r </i>= -0.488, <i>P </i>= 0.005). <b>Conclusions</b>PSMD was higher in TLE-HS patients than in the HC group and was associated with disease duration, seizure severity, and cognitive impairment. In TLE-NL patients, PSMD was associated with disease duration and cognitive function, but its association with seizure severity did not reach statistical significance. PSMD may serve as a potential imaging biomarker for white matter damage and disease progression in TLE. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Cerebral blood flow perfusion characteristics in preterm infants with bronchopulmonary dysplasia based on 3D-ASL and its correlation with duration of mechanical ventilation]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.006</link>
<description><![CDATA[<b>Objective</b>Using three-dimensional arterial spin labeling (3D-ASL) technology to investigate cerebral blood flow perfusion characteristics and their correlation with mechanical ventilation duration in preterm infants with bronchopulmonary dysplasia (BPD). <b>Materials and Methods</b>A total of 122 preterm infants who were hospitalized in the Neonatal Intensive Care Unit of the Third Affiliated Hospital of Zhengzhou University from January 2024 to September 2024 and underwent magnetic resonance imaging (MRI) examination in the Department of Radiology were prospectively and consecutively enrolled as study subjects. According to the diagnostic criteria for BPD, the patients were divided into a BPD group (<i>n </i>= 61) and a control group (<i>n </i>= 61). All subjects underwent conventional cranial MRI sequences and ASL sequence scanning at a corrected gestational age of 35 to 39 weeks. Cerebral blood flow (CBF) values were quantitatively measured in regions of interest, including the bilateral frontal, parietal, temporal, and occipital cortices and white matter, basal ganglia, and thalamus. Clinical data and CBF values were compared between the two groups. The effect of sex on CBF in the BPD group was analyzed, and partial correlation and subgroup-stratified analyses were performed within the BPD group to explore the correlation between CBF in the brain regions showing significant intergroup differences and the duration of mechanical ventilation. <b>Results</b>The duration of mechanical ventilation, invasive ventilation, and non-invasive ventilation in the BPD group was longer than that in the control group (<i>P </i>&lt; 0.05). Compared with the control group, the CBF values in the bilateral frontal cortex, bilateral parietal cortex, bilateral temporal cortex, bilateral occipital cortex, right frontal white matter, left parietal white matter, bilateral temporal white matter, right occipital white matter, bilateral basal ganglia and bilateral thalamus of the BPD group increased (<i>P </i>&lt; 0.05). Gender had no significant effect on CBF levels in various brain regions of preterm infants with BPD (<i>P </i>&gt; 0.05). In the overall BPD group (corrected gestational age 35~38 weeks), there was no significant correlation between CBF in the brain regions showing significant intergroup differences and the duration of mechanical ventilation (<i>P </i>&gt; 0.05); stratified analysis showed that in the subgroup with a corrected gestational age of 37 to 38 weeks, CBF in the left parietal white matter (<i>r </i>= 0.421, <i>P </i>= 0.040) and right occipital white matter (<i>r </i>= 0.476, <i>P </i>= 0.019) was significantly positively correlated with the duration of mechanical ventilation. <b>Conclusions</b>3D-ASL can reveal CBF perfusion abnormalities in preterm infants with BPD. In preterm infants with BPD at corrected gestational age of 37 to 38 weeks, there is a positive correlation between left parietal white matter and right occipital white matter CBF and mechanical ventilation duration. Clinical attention should be paid to the blood flow changes in the aforementioned brain regions of children undergoing long-term mechanical ventilation, optimizing respiratory support strategies, and strengthening neurodevelopmental follow-up. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Predictive value of DTI-ALPS combined with FA and standard MRI quantitative parameters for IDH mutation in adult-type diffuse high-grade gliomas]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.007</link>
<description><![CDATA[<b>Objective</b>To explore the predictive value of combining diffusion tensor image analysis along the perivascular space (DTI-ALPS), fractional anisotropy (FA) and standard MRI quantitative parameters for isocitrate dehydrogenase (IDH) mutation status in adult-type diffuse high-grade gliomas. <b>Materials and Methods</b>A total of 106 patients with adult-type diffuse high-grade gliomas who underwent standard MRI and diffusion tensor imaging (DTI) examinations and were definitively diagnosed by postoperative histopathological examination were enrolled in this retrospective analysis. The clinical, imaging and pathological data of all patients were collected. Standard MRI quantitative parameters were obtained by layer-by-layer delineation of the entire tumor using 3D-Slicer software. DSI studio software was applied to calculate FA and mean diffusivity (MD) in the tumor and peritumoral edema regions, as well as the ALPS index on the ipsilateral and contralateral sides of the tumor. Clinical data, standard MRI quantitative parameters, DTI metrics and ALPS index were compared between IDH wild-type and IDH-mutant groups. Univariate and multivariate analyses were performed for indicators with statistically significant intergroup differences. Multivariate binary logistic regression analysis was used to identify the optimal diagnostic parameters for predicting IDH mutation status. Receiver operating characteristic (ROC) curves were plotted to evaluate diagnostic efficiency. <b>Results</b>Tumor FA, tumor MD, ipsilateral ALPS index, contralateral ALPS index, tumor parenchymal volume, peritumoral edema volume, tumor-to-edema volume ratio and age were significantly different between the IDH wild-type and IDH-mutant groups (<i>P </i>&lt; 0.05). Multivariate binary logistic regression analysis revealed that age, tumor parenchymal volume, peritumoral edema volume, tumor FA and ipsilateral ALPS index were independent predictors of IDH mutation status. DeLong test indicated that the ipsilateral ALPS index and tumor FA exerted distinct incremental predictive values based on corresponding baseline models. ROC curve analysis demonstrated that the combined model incorporating age, standard MRI quantitative parameters, DTI metrics and ALPS index achieved the optimal predictive performance for IDH mutation status in adult-type diffuse high-grade gliomas. The area under the curve (AUC) was 0.952, with a sensitivity of 89.0%, specificity of 97.0% and accuracy of 93.4%. After 1000 bootstrap internal validation, the corrected 95% confidence interval <i>(CI</i>) of AUC was 0.879 to 0.995. The area under the precision-recall curve (PR-AUC) was 0.933, and the Brier score was 0.062, suggesting favorable model calibration. <b>Conclusions</b>DTI-ALPS combined with FA and standard MRI quantitative parameters shows good efficacy in predicting IDH mutation in adult-type diffuse high-grade gliomas. Ipsilateral ALPS index and tumor FA yield extra diagnostic value and can serve as imaging evidence for preoperative assessment and individualized treatment. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Predictive value of normalized epicardial adipose tissue volume for left ventricular reverse remodeling in dilated cardiomyopathy based on CMR]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.008</link>
<description><![CDATA[<b>Objective</b>To investigate the predictive value of epicardial adipose tissue (EAT) parameters derived from cardiac magnetic resonance (CMR) for left ventricular reverse remodeling (LVRR) in patients with dilated cardiomyopathy (DCM). <b>Materials and Methods</b>A total of 73 patients with DCM treated at Yijishan Hospital of Wannan Medical University from May 2023 to July 2025 were retrospectively enrolled. Clinical data, echocardiographic parameters, and CMR-derived parameters including cardiac functional parameters, EAT thickness, epicardial adipose tissue volume (EATV), and late gadolinium enhancement (LGE) percentage (LEG%) were collected. All patients received guideline-directed medical therapy and were followed up by echocardiography for 12 months. Patients were divided into the LVRR and non-LVRR groups according to the occurrence of LVRR. Baseline clinical and CMR data were compared between the two groups. Variables with statistically significant differences in univariate analysis (<i>P </i>&lt; 0.05), except for normalized EATV and LGE extent  LGE%, were entered into stepwise logistic regression to construct the baseline model (Model 1). Normalized EATV and LGE% were then separately added to Model 1 to construct Model 2 and Model 3, respectively. Finally, both normalized EATV and LGE% were added to construct the combined model. The area under the receiver operating characteristic curve (AUC) was calculated for each model, and predictive performance was compared using the DeLong test. Spearman correlation analysis and mediation analysis were used to explore the relationship between EAT indices and LGE%. <b>Results</b>At baseline, the LVRR group had a higher proportion of women and a higher body mass index, whereas left ventricular end-diastolic volume (LVEDV), left ventricular end-diastolic volume index (LVEDVi), left ventricular end-systolic volume (LVESV), right ventricular free wall (RVFW) thickness, EATV, normalized EATV, and LGE% were all significantly lower than those in the non-LVRR group (all <i>P </i>&lt; 0.05). After adjustment for potential confounders, stepwise multivariate logistic regression analysis identified female sex (<i>P</i> = 0.019), normalized EATV (<i>P</i> = 0.010), and LGE% (<i>P</i> = 0.023) as independent predictors of LVRR. The AUCs of Model 1, Model 2, Model 3, and the combined model for predicting LVRR were 0.765, 0.857, 0.856, and 0.891, respectively. DeLong test showed that Model 2 (<i>P</i> = 0.028), Model 3 (<i>P</i> = 0.043), and the combined model (<i>P</i> = 0.018) all demonstrated significantly better predictive performance than Model 1, whereas no significant differences were observed among Model 2, Model 3, and the combined model (all <i>P </i>&gt; 0.05). Correlation analysis showed that EATV and normalized EATV were significantly positively correlated with LGE% (<i>r</i> = 0.613 and 0.624, respectively; both <i>P </i>&lt; 0.001). Mediation analysis demonstrated that LGE% partially mediated the association between normalized EATV and LVRR, with a mediation proportion of 39.10% (<i>P</i> = 0.030). <b>Conclusions</b>Normalized EATV is an independent predictor for LVRR in patients with DCM, and its effect is partially mediated by promoting myocardial fibrosis. Quantitative EAT parameters and LGE% obtained from one-stop CMR imaging may serve as objective imaging markers for treatment response and prognostic stratification in patients with DCM. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Multimodal MRI combined with clinicopathological indicators to predict pathological complete response of axillary lymph nodes after neoadjuvant therapy for breast cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.009</link>
<description><![CDATA[<b>Objective</b>To establish a prediction model for axillary pathological complete response (pCR) after neoadjuvant therapy (NAT) in breast cancer patients with initially positive axillary lymph nodes, by integrating multimodal MRI features of the breast, axillary lymph nodes and peritumoral region before and after treatment, as well as clinicopathological indicators, and to evaluate its predictive performance. <b>Materials and Methods</b>A retrospective analysis was performed on patients with breast cancer and axillary lymph node metastasis admitted to our hospital from January 2022 to August 2025. MR imaging data and clinicopathological information before and after NAT were collected. Patients were randomly divided into a training set and a validation set at a ratio of 8:2. Logistic regression was used to screen independent predictors of axillary pCR and construct a nomogram. The model performance was assessed using receiver operating characteristic (ROC) curves, calibration curves and decision curve analysis (DCA), and bootstrap resampling (1000 times) was performed for internal validation to evaluate model stability. <b>Results</b>A total of 197 patients were included, with an axillary pCR rate of 58.38%. Positive HER-2 status, disappearance of peritumoral edema after NAT, and non-enhancement of residual lesions were identified as independent predictive factors (<i>P</i> &lt; 0.05). The model achieved an area under the ROC curve (AUC) of 0.895 (95% <i>CI</i>: 0.839 to 0.943) in the training set and 0.895 (95% <i>CI</i>: 0.773 to 0.984) in the validation set. The bootstrap-corrected optimism-corrected AUC was 0.893 (95%<i> CI</i>: 0.846 to 0.944). The Hosmer-Lemeshow test indicated good model fitting, and DCA showed significant net clinical benefit within a threshold probability range of 12% to 90%. <b>Conclusions</b>The model established in this study can effectively predict axillary pCR after NAT in breast cancer patients with initially positive axillary lymph nodes, with favorable discrimination and calibration. It can provide evidence for individualized surgical decision-making for the axilla, reduce unnecessary axillary lymph node dissection (ALND), and improve patient prognosis. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[The value of APTw imaging in the differential diagnosis of prostatic diseases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.010</link>
<description><![CDATA[<b>Objective</b>To explore the value of amide proton transfer weight (APTw) imaging in the differential diagnosis of prostatitis, prostatic hyperplasia (BPH) and prostate cancer (PCa). <b>Materials and Methods</b>A retrospective analysis was made on 133 patients with prostate diseases who underwent 3.0 T MRI scanning and were confirmed by pathology, including 41 cases of BPH, 23 cases of prostatitis and 69 cases of PCa. APTw values of all lesions were measured by two observers. Intra-class correlation coefficient (ICC) was used to test the consistency of APTw values measured by two observers. The age and prostate specific antigen [including total prostate specific antigen (tPSA) and free prostate specific antigen (fPSA)] of all patients were recorded. Multivariate logistic regression was used to screen possible independent risk factors of PCa. Firstly, the differences of parameters between benign and malignant groups were compared, and then the comparisons among PCa, BPH and prostatitis were made. T-test was used to compare the differences between benign and malignant lesions, and one-way analysis of variance (ANOVA) was used to compare the differences of quantitative parameters among the three groups. The measurement data conforming to the skewed distribution are expressed by the median (interquartile interval), and the differences between different groups are compared by Mann-Whitney rank sum test. The receiver operating characteristic (ROC) curve was used to evaluate the diagnostic efficacy of different parameters in different groups. DeLong test was used to compare the diagnostic efficiency of each parameter and joint parameters. <b>Results</b>The APTw values measured by the two observers are in good agreement (ICC &gt; 0.75). Multivariate logistic regression analysis showed that age and tPSA were possible independent risk factors for screening PCa (<i>P</i> &lt; 0.05). Compared with benign prostate diseases (prostatitis and BPH), the age, tPSA and APTw values of PCa group were all higher than those of benign prostate diseases group, the differences were statistically significant (<i>P</i> &lt; 0.05). Compared with PCa, BPH and prostatitis, PCa group was older than BPH group, and the difference was statistically significant (<i>P</i> &lt; 0.05), but there was no statistical difference among other groups. tPSA in PCa group was higher than that in prostatitis group and BPH group, and the differences were statistically significant (<i>P</i> &lt; 0.05), there was no significant difference in tPSA between prostatitis group and BPH group (<i>P</i> &gt; 0.05). The APTw value in PCa group was higher than that in prostatitis group and BPH group, and the difference was statistically significant (<i>P</i> &lt; 0.05), but there was no statistical difference between prostatitis group and BPH group (<i>P</i> &gt; 0.05). The clinical indicators (age, tPSA), APTw value and the area under ROC curve (AUC) of APTw combined with clinical indicators in differentiating benign and malignant prostate lesions were 0.754, 0.755 and 0.838, respectively, and the diagnostic efficiency of clinical indicators and APTw value combined with clinical indicators was statistically significant (<i>P</i> &lt; 0.05). The AUC of tPSA, APTw and APTw combined with tPSA in differentiating PCa from prostatitis were 0.680, 0.739 and 0.783, respectively, and there was no significant difference in diagnostic efficiency (<i>P</i> &gt; 0.05). <b>Conclusions</b>APT value has a good clinical application prospect in differentiating benign and malignant prostate diseases. Combined with clinical indicators, it can improve the diagnostic efficiency, and can well distinguish PCa from prostatitis and BPH. In addition, APTw value combined with tPSA value can improve the diagnosis of PCa and prostatitis to a certain extent, providing new ideas for clinical diagnosis and subsequent treatment methods. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Consistency study of cerebral blood flow measurements between enhanced arterial spin labeling and three-dimensional arterial spin labeling]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.011</link>
<description><![CDATA[<b>Objective</b>To evaluate the consistency of cerebral blood flow (CBF) measurements between enhanced arterial spin labeling (eASL) and three-dimensional arterial spin labeling (3D-ASL) in different brain regions. <b>Materials and Methods</b>Thirty healthy volunteers (11 males, 19 females; mean age ± SD: 23 ± 7 years) were recruited between March 2024 and March 2025. All participants underwent both eASL  (TR 9584 ms, with multiple post-labeling delays of 1.000, 1.361, 1.739, 2.141, 2.577, 3.067, and 3.658 s) and 3D-ASL (TR 4308 ms,PLD: 1.025 s, 2.025 s) scanning on a 3.0 T MR scanner. After head motion correction, spatial registration, and other preprocessing steps, a kinetic model was applied to the multi-delay eASL data to generate quantitative CBF maps. CBF values from 54 anatomical subregions, including cerebral lobes, deep nuclei, deep perforating artery territories, cerebellum, and others, were extracted and compared between the two techniques. The relative difference indices (normalized to the ipsilateral cerebrum and cerebellum, respectively) were also calculated. Statistical analyses were performed using SPSS Statistics 27.0. The Kolmogorov-Smirnov test was used to assess the normality of data distribution, and Levene<sup><sup>,</sup></sup>s test was used to assess homogeneity of variances. Paired <i>t</i>-tests or Wilcoxon signed-rank tests were performed accordingly. All statistical results were corrected using FDR. Bland-Altman analysis was used to evaluate the agreement between the two techniques, and intra-class correlation coefficients (ICC) were calculated. <b>Results</b>Among the 54 brain regions, paired <i>t</i>-tests were performed on 48 regions, and Wilcoxon signed-rank tests were performed on the remaining 6 regions. Significant differences in CBF values were observed in 48.15% (26/54) of brain regions (<i>P</i> &lt; 0.05). eASL yielded significantly higher CBF values in the cerebral cortex and cerebellum compared to 3D-ASL. Conversely, in some deep nuclei, eASL yielded lower CBF values than 3D-ASL. Analysis of arterial transit time (ATT) revealed a clear stratification: cortical and cerebellar regions had longer ATTs (1.30 to 1.45 s), whereas deep nuclei and deep perforating territories had shorter ATTs (1.05 to 1.20 s). Bland-Altman analysis indicated a mean CBF difference of 3.57 mL/(100 g·min) across all regions, with an ICC(A,1) of 0.63, indicating moderate agreement but notable inter-individual variability. <b>Conclusions</b>There are significant region-dependent differences in cerebral blood flow perfusion measurements between eASL and 3D-ASL. The ATT of intracerebral arteries exhibits a typical regional layered distribution. In clinical quantitative assessment of cerebral perfusion, attention should be paid to the regional measurement differences between the two ASL sequences, and scanning protocols should be optimized to improve the accuracy of cerebral hemodynamic evaluation. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of magnetic resonance elastography in Alzheimer<sup><sup>,</sup></sup>s disease]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.012</link>
<description><![CDATA[Alzheimer<sup><sup>,</sup></sup>s disease (AD) is a neurodegenerative disorder with an insidious onset and a progressive course, characterized by persistent cognitive decline and region-specific pathologies. Early identification of AD and elucidation of its underlying biological mechanisms remain key challenges in both clinical and basic research. Magnetic resonance elastography (MRE) is a rapidly evolving non-invasive imaging technique that applies low-frequency mechanical waves to brain tissue and acquires quantitative parameters reflecting tissue stiffness and viscoelasticity using MRI. It offers a novel approach to investigating the evolution of the brain<sup><sup>,</sup></sup>s mechanical microenvironment during AD progression and shows promise in assisting early diagnosis and disease monitoring. This review systematically summarizes the current applications of MRE in AD research, covering early detection, disease progression tracking, and the association between brain mechanical property changes and pathological processes. It also identifies limitations in sample size and technical standardization, and proposes future directions toward protocol harmonization and multicenter longitudinal validation. This review aims to provide clinicians and AD researchers with a systematic reference from technical principles to clinical applications. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in MRI studies on visual cortex abnormalities in major mental disorders]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.013</link>
<description><![CDATA[Major psychiatric disorders (MPD), including major depressive disorder (MDD), bipolar disorder (BD), and schizophrenia (SZ), are characterized by high disability and recurrence rates. Their diagnosis and treatment remain challenging because of complex clinical manifestations, unclear pathophysiological mechanisms, and lack of reliable neuroimaging biomarkers. The visual cortex is not only responsible for visual information processing but also plays important roles in emotion regulation, cognitive processing, and other higher-order brain functions. Moreover, patients with MPD commonly exhibit impairments in visual perception and cognition, making the visual cortex an increasingly important focus of neuroimaging research in psychiatric disorders. However, current studies are limited by relatively small sample sizes, predominantly cross-sectional designs, and considerable methodological heterogeneity. Future large-scale, multicenter, longitudinal, and transdiagnostic studies integrating multimodal MRI and neuromodulation techniques are warranted to further elucidate the neuropathological mechanisms underlying visual cortex abnormalities and facilitate their clinical translation. This review summarizes recent MRI studies on visual cortex abnormalities in MPD and compares the shared and disorder-specific characteristics of major depressive disorder, schizophrenia, and bipolar disorder from a transdiagnostic perspective, with the aim of providing a reference for further elucidating the neuropathological mechanisms of MPD and exploring visual cortex-related neuroimaging biomarkers and neuromodulation targets. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in diffusion tensor imaging of corticospinal tract remodeling for motor recovery after stroke with acupuncture and moxibustion]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.014</link>
<description><![CDATA[The corticospinal tract (CST) is a core neural pathway for motor function recovery after stroke. Diffusion tensor imaging (DTI), as a non-invasive and objective technique, can quantitatively assess the microstructure of the CST through relevant imaging parameters and has been widely applied in stroke research. Unraveling the central mechanism of acupuncture and moxibustion in treating motor dysfunction after stroke (MDAS) based on DTI technology is a key focus in the current field of acupuncture efficacy research. This review systematically summarizes the anatomical structure and function of the CST, as well as the technical principles, core indicators, imaging features, and fiber tractography methods of DTI for CST evaluation, along with DTI-based evidence on acupuncture and moxibustion intervention for MDAS. Based on the available evidence, this review discusses the possible mechanisms by which acupuncture and moxibustion induce motor function recovery and neural remodeling, while pointing out the limitations of current studies and future research directions, with the aim of providing new insights into improving the efficacy of acupuncture and moxibustion in treating MDAS. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of resting-state functional magnetic resonance imaging in post-stroke cognitive impairment]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.015</link>
<description><![CDATA[Post-stroke cognitive impairment (PSCI) is one of the most common complications after stroke and has a significant impact on prognosis. The diagnosis of PSCI involves systematic assessments encompassing clinical symptoms, neuropsychological evaluations, and neuroimaging. Among these, resting-state functional magnetic resonance imaging (rs-fMRI) plays an important role in PSCI research. Rs-fMRI offers advantages such as non-invasiveness, lack of radiation exposure, and high sensitivity, making it well-suited for use in stroke populations. It can directly reflect post-stroke abnormalities in local neuronal activity, functional connectivity (FC) between brain regions, and brain network topological properties, thereby enabling objective assessment of the degree of cognitive impairment in PSCI patients. Consequently, rs-fMRI has been widely applied in studies investigating the neural mechanisms of PSCI, identifying therapeutic targets, and evaluating treatment efficacy. However, to date, there are very few literature reviews specifically focusing on rs-fMRI in PSCI. Existing studies remain limited to conventional analytical metrics, with insufficient depth and dimensionality of analysis, and a lack of systematic synthesis regarding the mechanisms underlying PSCI treatment. Therefore, this review summarizes the main findings and specific applications of rs-fMRI in PSCI research, analyzes current limitations, and proposes future research directions, aiming to provide new insights into the neural mechanisms of PSCI as well as clinical diagnosis and treatment decision-making. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on the correlation between intracranial arterial remodeling and white matter hyperintensities]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.016</link>
<description><![CDATA[White matter hyperintensities (WMH) serve as the core imaging marker of cerebral small vessel disease and are strongly associated with cognitive decline and dementia. Brain arterial remodeling (BAR) refers to pathological structural alterations of large intracranial arteries. Previous studies have mostly focused on focal remodeling at plaque sites, which fails to reflect overall cerebrovascular lesions across the whole brain. The BAR score enables quantitative measurement of diffuse cerebral arterial remodeling and delivers a standardized assessment protocol. Widespread intracranial arterial dilative remodeling is independently correlated with severe WMH. Combined imaging biomarkers of the two conditions can be applied to stratify cognitive risk screening among general elderly populations, high-risk hypertensive groups and patients with mild cognitive impairment, thereby optimizing the risk stratification system for cerebral small vessel disease. Current research in this field lacks in vivo molecular evidence from human subjects, and multicenter cohort studies as well as combined quantitative investigations of vascular walls and microcirculation remain insufficient. Integrated vascular assessments based on AI radiomics and four-dimensional flow imaging in the future can supply imaging evidence for the early prevention and treatment of vascular cognitive impairment. This paper sorts out shared risk factors of BAR and WMH, distinguishes two independent regulatory pathways including blood flow shear stress and vascular inflammation, and illustrates the pathological cycle in which arterial remodeling and WMH exacerbate each other. It also integrates the diagnostic value of multimodal imaging, identifies discrepancies in conclusions of existing studies, and indicates that inconsistent assessment tools, varying study populations and differences in confounding factor adjustment constitute the primary causes of divergent results, offering references for clinical diagnosis and treatment. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in multimodal radiomics and deep learning for predicting TERT promoter status and assisting clinical decision-making in glioma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.017</link>
<description><![CDATA[Telomerase reverse transcriptase promoter mutation is a core molecular event in the molecular classification of gliomas. Detecting these mutations provides crucial guidance for patient prognosis assessment and the development of individualized treatment plans. Traditional detection methods rely on invasive tissue biopsy, which has inherent limitations such as tumor spatiotemporal heterogeneity, sampling bias, and the inability to perform dynamic monitoring, making it difficult to meet the clinical needs of precise diagnosis and treatment.In recent years, radiomics based on multiparametric MRI and deep learning technology have developed rapidly and have become an important research direction for non-invasive preoperative prediction of TERT promoter mutation status in gliomas. Research shows that some multimodal fusion models demonstrate certain generalization ability in limited external validation, but performance degradation across centers remains a common challenge. Meanwhile, the translation of this technology into routine clinical practice still faces key challenges, including image standardization, cross-center data sharing, and insufficient model interpretability. Looking ahead, by promoting large-scale prospective clinical trials, establishing standardized cross-center imaging databases, integrating spatial multi-omics and liquid biopsy cross-modal information, and optimizing models with technologies such as federated learning and explainable AI, it is hoped that imaging AI prediction models can be transformed into reliable clinical decision-support tools, advancing intelligent and individualized glioma diagnosis and treatment. This review systematically summarizes the latest research progress in this field, focusing on the methodological construction, model performance optimization, and clinical translation value of multi-modal radiomics and deep learning models in predicting TERT promoter mutations in gliomas. It also analyzes core development features in current research, such as model refinement, multi-modal fusion, and interpretability exploration, aiming to provide methodological reference for non-invasive preoperative prediction of TERT promoter mutations in gliomas. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of amide proton transfer imaging in the diagnosis and efficacy evaluation of brain metastases]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.018</link>
<description><![CDATA[Brain metastases (BMs) are common malignant tumors of the central nervous system and severely affect patients<sup><sup>,</sup></sup> prognosis and quality of life. Therefore, accurate diagnosis and treatment response assessment of BMs are of great significance for clinical management. Amide proton transfer (APT) imaging, as a branch of chemical exchange saturation transfer (CEST) technology, can noninvasively detect intratumoral protein concentration and changes in the metabolic microenvironment, and has shown some potential in studies related to the diagnosis and treatment of central nervous system tumors in recent years. However, current studies on APT imaging in BMs still have several limitations, including relatively small sample sizes, inconsistent scanning parameters and post-processing workflows, differences in APT quantitative metrics and region-of-interest selection, and scattered evidence regarding pathology-related assessment and post-treatment efficacy assessment, and there is a relative lack of systematic reviews specifically focused on BMs. Accordingly, this article reviews the application progress of APT imaging in the differential diagnosis, pathology-related assessment, and post-treatment efficacy assessment of BMs, and discusses its clinical value and future development directions. This review aims to summarize the key evidence and existing challenges of APT imaging in the evaluation of BMs, demonstrate its potential value in improving diagnostic accuracy and post-treatment monitoring of BMs, and provide a reference for future study design and clinical translation. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Progress in multimodal cardiac magnetic resonance for the evaluation of myocardial injury in obese patients]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.019</link>
<description><![CDATA[Obesity is a major risk factor for cardiovascular diseases. Myocardial injury induced by obesity can occur in patients with preserved left ventricular ejection fraction (LVEF). Early and accurate identification of such subclinical injuries is critical for preventing heart failure in obese individuals. However, conventional imaging modalities including ultrasound and computed tomography have notable limitations when applied to obese patients. Multimodal cardiac magnetic resonance (CMR), with the advantages of non-invasiveness and freedom from ionizing radiation, has emerged as a pivotal imaging tool and shows great potential in comprehensive myocardial evaluation. At present, there is a lack of systematic integration regarding the cross-sequence application value of multimodal CMR in assessing obesity-induced myocardial microcirculation disorders, myocardial strain abnormalities and metabolic dysfunction. Additionally, the dose-effect relationships between various CMR sequences and obesity-related myocardial injury remain unclear. This review comprehensively summarizes the research progress of multimodal CMR techniques, including cine imaging, late gadolinium enhancement (LGE), T1/T2 mapping, first-pass perfusion and myocardial spectroscopy, in assessing cardiac structure, myocardial strain, myocardial metabolism and myocardial microcirculation in obese patients. Current CMR studies on obesity-induced myocardial injury are predominantly single-center and single-sequence based. Although each of the above sequences has its own advantages, based on the analysis of the advantages and limitations of existing CMR approaches, we propose that future studies should focus on multi-center and multi-sequence design, the introduction of emerging technologies, and the promotion of multimodal imaging fusion. This review aims to provide an imaging reference for early risk stratification and dynamic efficacy monitoring of myocardial injury in obese patients. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research advances in artificial intelligence-assisted cardiac magnetic resonance imaging analysis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.020</link>
<description><![CDATA[Cardiac magnetic resonance (CMR) enables comprehensive assessment of cardiac structure, function, perfusion, and myocardial tissue characteristics, and plays an important role in the diagnosis, risk stratification, and therapeutic evaluation of cardiovascular diseases. However, CMR image post-processing is relatively complex, and conventional manual analysis is time-consuming, subjective, and limited in reproducibility, which restricts its further application in large-scale studies and efficient clinical practice. In recent years, artificial intelligence (AI) has been increasingly applied to CMR image analysis and has shown promising potential in automatic segmentation, functional quantification, tissue characterization, disease identification, risk prediction, dynamic spatiotemporal modeling, image reconstruction, and data augmentation. This review is organized around major CMR image analysis tasks and focuses on recent advances in AI-based automatic segmentation and functional quantification, tissue characterization and disease differentiation, risk prediction, dynamic spatiotemporal modeling, image reconstruction, and data augmentation. It also summarizes the applicable scenarios, representative findings, and current limitations of different techniques. Current AI-CMR research remains challenged by data heterogeneity, inconsistent annotation standards, insufficient external validation, limited cross-center generalizability, and inadequate interpretability of model outputs. This review aims to provide a reference for the design of AI-CMR-related studies, model optimization, and subsequent applications, with the goal of advancing CMR image analysis toward greater standardization, automation, and precision, while offering new perspectives for precision diagnosis, risk prediction, and individualized management of cardiovascular diseases. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in CT and MRI for the assessment of progressive pulmonary fibrosis]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.021</link>
<description><![CDATA[Interstitial lung disease (ILD) encompasses a heterogeneous group of disorders characterized by diverse patterns of evolution and markedly variable prognoses. Compared to patients experiencing spontaneous resolution or disease stabilization, those with progressive pulmonary fibrosis (PPF) face a significantly poorer prognosis and elevated mortality risk. Consequently, early diagnosis and risk stratification in PPF have emerged as critical unmet clinical needs. Imaging plays an integral role throughout the entire disease trajectory of PPF, contributing substantially to disease screening, longitudinal monitoring, and prognostic assessment. High-resolution computed tomography (HRCT) remains the cornerstone of PPF diagnosis and management, and CT technology continues to undergo iterative advancements. However, X-ray-based imaging modalities, including photon-counting computed tomography (PCCT), are associated with inherent risks of ionizing radiation exposure. In recent years, the rapid evolution of magnetic resonance imaging (MRI) has enabled parenchymal lung imaging, offering a multi-dimensional perspective for the radiation-free assessment of PPF. This article reviews the research progress of HRCT and MRI in the evaluation of PPF, and discusses current technical limitations and future directions, with the aim of facilitating early diagnosis, tracking disease progression, and guiding clinical management. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in the application of MRI for evaluating therapeutic efficacy of major treatment modalities in lung cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.022</link>
<description><![CDATA[Lung cancer is a malignant tumor that poses a serious threat to human health. With the development of precision medicine and the expanding use of immunotherapy, targeted therapy, radiotherapy and chemotherapy, evaluation of therapeutic efficacy has become a key component of individualized treatment for lung cancer. Magnetic resonance imaging (MRI), which does not involve ionizing radiation and offers multiparametric and multidimensional imaging capabilities, can dynamically reflect tumor responses to treatment in terms of perfusion, diffusion, microstructure and functional status, providing a sound basis for its application in evaluating therapeutic efficacy in lung cancer. Existing studies have mainly focused on a single treatment modality, MRI technique or evaluation scenario, while MRI parameters, clinical value and limitations across different treatment modalities have not yet been comprehensively summarized. Focusing on four major treatment modalities, immunotherapy, targeted therapy, radiotherapy and chemotherapy, this review summarizes advances in the application of functional MRI and related emerging techniques for evaluating therapeutic efficacy in lung cancer. It specifically summarizes the value of these techniques in benefit stratification, response monitoring and differentiation of pseudoprogression during immunotherapy; efficacy evaluation and resistance monitoring during targeted therapy; radiotherapy guidance and preservation of pulmonary function; and chemosensitivity assessment and differentiation of complex lesions during chemotherapy. This review also analyzes current limitations, including insufficient standardization, small sample sizes and poor reproducibility, and proposes future directions focusing on standardized workflows, multicenter prospective validation and multimodal information integration, with the aim of providing a reference for the standardized application of MRI in evaluating therapeutic efficacy in lung cancer. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Application progress of multi-parametric magnetic resonance imaging radiomics in the diagnosis and treatment of lung cancer]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.023</link>
<description><![CDATA[Lung cancer is the most prevalent malignancy worldwide. Magnetic resonance imaging (MRI) is non-ionizing, offers excellent soft-tissue resolution, and has versatile sequences. It plays a significant role in the precise evaluation of local tumor invasion, differentiating post-treatment changes and following up on high-risk populations. Additionally, it complements conventional CT and PET/CT effectively. As an emerging analytical technique that has developed rapidly in the field of medical imaging in recent years, radiomics has been shown in numerous studies to enable non-invasive precise diagnosis, individualized treatment decision-making and therapeutic response monitoring of lung cancer via radiomic models constructed by combining high-throughput quantitative imaging features with clinical data. As an emerging interdisciplinary method, mpMRI-based radiomics shows great potential in lung cancer diagnosis and treatment, but faces challenges including insufficient standardization of multi-center data, low feature reproducibility and inadequate model generalization ability. This review summarizes the applications of mpMRI radiomics in the precise diagnosis, classification, and staging of lung cancer, as well as the evaluation of treatment response and prognosis assessment, discusses current limitations and challenges, and aims to provide a reference for clinical decision-making in lung cancer, and to offer new perspectives for future research directions in this field. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress of gadoxetic acid disodium-enhanced MRI in predicting microvascular invasion of hepatocellular carcinoma]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.024</link>
<description><![CDATA[Hepatocellular carcinoma (HCC) is one of the most common tumors worldwide, with a high recurrence rate and poor prognosis after treatment. Microvascular invasion (MVI), as a core marker of the aggressive biological behavior of HCC, is an important factor affecting the postoperative recurrence and survival of HCC patients. Currently, the diagnosis of MVI mainly relies on postoperative pathological biopsy, which is invasive and lagging, and cannot provide a precise assessment of the MVI risk level for patients before surgery for clinicians, thus failing to guide the formulation of preoperative neoadjuvant treatment plans. It also cannot provide guidance for the selection of surgical methods and the setting of surgical margins during the operation, and is of no help for preoperative planning and intraoperative decision-making. Traditional imaging examinations (such as CT and conventional ultrasound) have a low sensitivity in showing MVI. Gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (GD-EOB-DTPA), as a liver cell-specific contrast agent, its imaging signs can effectively evaluate the MVI risk and play an important role in non-invasive prediction of HCC MVI before surgery. On this basis, the development of artificial intelligence technology provides a new path for the preoperative prediction of MVI in HCC. This article breaks through the limitations of previous reviews that "generalize and cover multiple imaging techniques", and takes GD-EOB-DTPA-enhanced MRI as the main thread. This article will review the current research status of GD-EOB-DTPA enhanced MRI imaging signs and related radiomics, habitat imaging and deep learning in predicting HCC MVI, providing personalized treatment for HCC patients and references for clinical diagnosis and treatment. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on microvascular invasion of hepatocellular carcinoma based on multi-parametric MRI radiomics and extracellular volume]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.025</link>
<description><![CDATA[Hepatocellular carcinoma (HCC) is a highly aggressive and recurrent primary liver malignancy, with microvascular invasion (MVI) serving as an independent prognostic factor for patient outcomes. Non-invasive preoperative prediction of MVI using imaging techniques is crucial for developing personalized treatment strategies. In recent years, radiomics based on multi-parametric magnetic resonance imaging (mpMRI) and extracellular volume (ECV) quantification have shown promising applications in characterizing tumor heterogeneity and the tumor microenvironment, respectively. However, existing literature predominantly focuses on individual technological advances, lacking comprehensive summaries of the theoretical foundations and cutting-edge findings regarding their combined use. This article systematically reviews the latest research progress in applying mpMRI-based radiomics and ECV for HCC MVI assessment, emphasizing advancements in mpMRI radiomics, the principles of ECV quantification, its pathological association with MVI, and the theoretical framework for integrating both approaches in non-invasive preoperative evaluation of HCC MVI. It further analyzes key challenges in current studies: including inconsistent label quality, cross-modal registration errors, and limited model interpretability, and proposes corresponding optimization strategies. The aim is to provide actionable theoretical guidance and methodological insights for precise preoperative risk stratification in HCC and future multimodal integration research. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Advances in radiomics for rectal cancer immunotherapy: From treatment response assessment to prognostic prediction]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.026</link>
<description><![CDATA[Rectal cancer is the third most common malignancy worldwide, and its disease burden continues to intensify. Immunotherapy for rectal cancer has garnered increasing attention. Radiomics, as a medical image analysis technique, provides a novel tool for the precise assessment of rectal cancer immunotherapy. By extracting quantitative features from multi-modal images, including computed tomography (CT), magnetic resonance imaging (MRI), and positron emission tomography (PET), it can effectively predict microsatellite instability (MSI) status, identify pseudoprogression, and evaluate immunotherapy response. However, it also faces challenges in data standardization (such as scanner variability and segmentation heterogeneity), multi-modal fusion (such as stringent cross-modal registration accuracy and complex modality-specific preprocessing), and clinical translation (such as lack of external validation and insufficient model interpretability). Existing reviews predominantly focus on neoadjuvant chemoradiotherapy but lack specific focus on this particular direction of rectal cancer immunotherapy; moreover, they lack in-depth analysis and integrated discussion of critical bottlenecks such as identifying benefiting populations and differentiating pseudoprogression. Therefore, this article reviews the current application status, technical workflow, and challenges of radiomics in rectal cancer immunotherapy, and analyzes its application value and limitations in pre-treatment assessment, efficacy evaluation, and post-treatment follow-up. The aim is to provide new insights for establishing standardized workflows, conducting prospective multi-center validation studies, and constructing full-cycle decision-support systems. Future research should prioritize developing standardized imaging protocols tailored to immunotherapy scenarios, building multi-modal multi-omics fusion models, developing AI algorithms with clinical semantic interpretability, and launching large-scale prospective clinical trials to facilitate the translation of radiomics from retrospective research to clinical decision-support tools. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
<item>
<title><![CDATA[Research progress on AI-based multimodal MRI in the diagnosis and treatment decision-making of cervical spondylotic myelopathy]]></title>
<link>http://med-sci.cn/cgzcx/en/en_articlexml.asp?doi=10.12015/issn.1674-8034.2026.08.027</link>
<description><![CDATA[Artificial intelligence (AI) technologies, spearheaded by deep learning (DL), have emerged as a prominent research focus in neuroimaging due to their remarkable capabilities in extracting complex image features and analyzing nonlinear data. In the diagnosis and management of cervical spondylotic myelopathy (CSM), AI is no longer confined to automated image segmentation, but rather encompasses key stages including quantitative assessment, multimodal feature analysis, and functional prognosis prediction. It facilitates not only early and precise lesion identification with objective grading, overcoming the lack of objectivity in conventional MRI manual visual evaluation, but also assists in forecasting postoperative neurological recovery trends, thereby supporting clinicians in devising individualized surgical plans and rehabilitation strategies. Although some studies have explored the application of AI in cervical spine diseases, existing reviews are mostly limited to morphological analysis of a single conventional magnetic resonance imaging (MRI) sequence or a single diagnostic stage, lacking a systematic summary regarding the application value of the deep integration of multimodal MRI and AI in CSM, such as diffusion tensor imaging, diffusion basis spectrum imaging, and resting-state functional MRI. In particular, insufficient attention has been paid to how AI reveals the micro-pathological evolution of the spinal cord and the functional remodeling of the "brain-spinal cord axis". To fill this gap, this review synthesizes recent advances in AI-integrated multimodal MRI for early screening, auxiliary diagnosis, and prognosis prediction in CSM, aiming to explore current challenges and future prospects within this domain from the perspectives of pathophysiological representation and full-chain diagnostic and treatment decision-making, with the hope of providing new insights and academic references for the clinical translation practice of AI-based multimodal MRI technology in the precision diagnosis and treatment of CSM. ]]></description>
<pubDate>Thu,20 Aug 2026 00:00:00  GMT</pubDate>
</item>
</channel>
</rss>
